Num | GO | Overlap | Size | P Value | Adj. P Value |
1 |
NOTCH SIGNALING PATHWAY |
12 |
114 |
3.506e-13 |
8.198e-10 |
2 |
PROTEOLYSIS |
29 |
1208 |
3.524e-13 |
8.198e-10 |
3 |
REGULATION OF CATABOLIC PROCESS |
21 |
731 |
4.474e-11 |
6.939e-08 |
4 |
POSITIVE REGULATION OF CATABOLIC PROCESS |
16 |
395 |
8.586e-11 |
8.944e-08 |
5 |
POSITIVE REGULATION OF CELL DEATH |
19 |
605 |
9.611e-11 |
8.944e-08 |
6 |
TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY |
17 |
498 |
2.955e-10 |
1.964e-07 |
7 |
NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
23 |
983 |
2.704e-10 |
1.964e-07 |
8 |
EPHRIN RECEPTOR SIGNALING PATHWAY |
9 |
85 |
3.391e-10 |
1.972e-07 |
9 |
PROTEIN MATURATION |
13 |
265 |
5.708e-10 |
2.656e-07 |
10 |
POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS |
13 |
263 |
5.202e-10 |
2.656e-07 |
11 |
POSITIVE REGULATION OF RESPONSE TO STIMULUS |
31 |
1929 |
1.292e-09 |
4.625e-07 |
12 |
REGULATION OF NOTCH SIGNALING PATHWAY |
8 |
67 |
1.278e-09 |
4.625e-07 |
13 |
REGULATION OF BINDING |
13 |
283 |
1.273e-09 |
4.625e-07 |
14 |
REGULATION OF PROTEOLYSIS |
19 |
711 |
1.433e-09 |
4.762e-07 |
15 |
CELLULAR RESPONSE TO OXYGEN LEVELS |
10 |
143 |
2.083e-09 |
6.462e-07 |
16 |
POSITIVE REGULATION OF PROTEOLYSIS |
14 |
363 |
2.697e-09 |
7.844e-07 |
17 |
POSITIVE REGULATION OF CELL COMMUNICATION |
27 |
1532 |
2.944e-09 |
8.058e-07 |
18 |
RESPONSE TO ABIOTIC STIMULUS |
22 |
1024 |
3.463e-09 |
8.951e-07 |
19 |
RESPONSE TO OXYGEN LEVELS |
13 |
311 |
3.982e-09 |
9.751e-07 |
20 |
POSITIVE REGULATION OF MOLECULAR FUNCTION |
29 |
1791 |
4.463e-09 |
1.038e-06 |
21 |
REGULATION OF CELL DEATH |
26 |
1472 |
5.989e-09 |
1.327e-06 |
22 |
REGULATION OF PROTEIN CATABOLIC PROCESS |
14 |
393 |
7.422e-09 |
1.57e-06 |
23 |
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA |
6 |
32 |
9.691e-09 |
1.961e-06 |
24 |
NEUROGENESIS |
25 |
1402 |
1.049e-08 |
2.034e-06 |
25 |
POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY |
6 |
34 |
1.427e-08 |
2.656e-06 |
26 |
POSITIVE REGULATION OF ERBB SIGNALING PATHWAY |
6 |
36 |
2.05e-08 |
3.669e-06 |
27 |
ERROR PRONE TRANSLESION SYNTHESIS |
5 |
19 |
2.806e-08 |
4.836e-06 |
28 |
ERBB2 SIGNALING PATHWAY |
6 |
39 |
3.394e-08 |
5.64e-06 |
29 |
POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS |
10 |
192 |
3.542e-08 |
5.683e-06 |
30 |
ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY |
17 |
689 |
3.771e-08 |
5.848e-06 |
31 |
NEGATIVE REGULATION OF MOLECULAR FUNCTION |
21 |
1079 |
4.634e-08 |
6.956e-06 |
32 |
REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS |
11 |
274 |
1.02e-07 |
1.483e-05 |
33 |
GLYCOGEN BIOSYNTHETIC PROCESS |
5 |
25 |
1.253e-07 |
1.714e-05 |
34 |
GLUCAN BIOSYNTHETIC PROCESS |
5 |
25 |
1.253e-07 |
1.714e-05 |
35 |
REGULATION OF NECROTIC CELL DEATH |
5 |
26 |
1.545e-07 |
2.054e-05 |
36 |
POSITIVE REGULATION OF BINDING |
8 |
127 |
2.065e-07 |
2.649e-05 |
37 |
NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS |
24 |
1517 |
2.106e-07 |
2.649e-05 |
38 |
CATABOLIC PROCESS |
26 |
1773 |
2.556e-07 |
3.129e-05 |
39 |
CELL DEVELOPMENT |
23 |
1426 |
2.853e-07 |
3.404e-05 |
40 |
REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT |
25 |
1672 |
3.221e-07 |
3.747e-05 |
41 |
CELLULAR GLUCAN METABOLIC PROCESS |
6 |
58 |
3.906e-07 |
4.227e-05 |
42 |
GLUCAN METABOLIC PROCESS |
6 |
58 |
3.906e-07 |
4.227e-05 |
43 |
CELLULAR RESPONSE TO STRESS |
24 |
1565 |
3.728e-07 |
4.227e-05 |
44 |
SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE |
7 |
96 |
4.558e-07 |
4.714e-05 |
45 |
GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR |
5 |
32 |
4.621e-07 |
4.714e-05 |
46 |
REGULATION OF RESPONSE TO STRESS |
23 |
1468 |
4.762e-07 |
4.714e-05 |
47 |
CELL CYCLE CHECKPOINT |
9 |
194 |
4.723e-07 |
4.714e-05 |
48 |
POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS |
23 |
1492 |
6.326e-07 |
6.132e-05 |
49 |
NOTCH RECEPTOR PROCESSING |
4 |
16 |
9.429e-07 |
8.536e-05 |
50 |
CELL CELL SIGNALING |
16 |
767 |
9.414e-07 |
8.536e-05 |
51 |
REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS |
6 |
67 |
9.296e-07 |
8.536e-05 |
52 |
NEGATIVE REGULATION OF CYTOKINE PRODUCTION |
9 |
211 |
9.54e-07 |
8.536e-05 |
53 |
VIRION ASSEMBLY |
5 |
37 |
9.81e-07 |
8.612e-05 |
54 |
NEGATIVE REGULATION OF CELL DEATH |
17 |
872 |
1.05e-06 |
9.043e-05 |
55 |
NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS |
19 |
1087 |
1.151e-06 |
9.736e-05 |
56 |
REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR |
8 |
162 |
1.322e-06 |
0.0001098 |
57 |
ENERGY RESERVE METABOLIC PROCESS |
6 |
72 |
1.427e-06 |
0.0001165 |
58 |
TRANSLESION SYNTHESIS |
5 |
41 |
1.661e-06 |
0.0001324 |
59 |
DNA SYNTHESIS INVOLVED IN DNA REPAIR |
6 |
74 |
1.679e-06 |
0.0001324 |
60 |
NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS |
14 |
616 |
1.797e-06 |
0.0001394 |
61 |
POLYSACCHARIDE BIOSYNTHETIC PROCESS |
5 |
42 |
1.878e-06 |
0.0001432 |
62 |
ERROR FREE TRANSLESION SYNTHESIS |
4 |
19 |
1.985e-06 |
0.000149 |
63 |
REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS |
18 |
1021 |
2.041e-06 |
0.0001508 |
64 |
IMMUNE SYSTEM PROCESS |
26 |
1984 |
2.19e-06 |
0.0001568 |
65 |
CARBOHYDRATE BIOSYNTHETIC PROCESS |
7 |
121 |
2.186e-06 |
0.0001568 |
66 |
REGULATION OF CELL ADHESION |
14 |
629 |
2.293e-06 |
0.0001616 |
67 |
NEGATIVE REGULATION OF GENE EXPRESSION |
22 |
1493 |
2.472e-06 |
0.0001643 |
68 |
REGULATION OF CANONICAL WNT SIGNALING PATHWAY |
9 |
236 |
2.408e-06 |
0.0001643 |
69 |
NEGATIVE REGULATION OF TRANSPORT |
12 |
458 |
2.465e-06 |
0.0001643 |
70 |
ERBB SIGNALING PATHWAY |
6 |
79 |
2.47e-06 |
0.0001643 |
71 |
POLYSACCHARIDE METABOLIC PROCESS |
6 |
80 |
2.659e-06 |
0.0001743 |
72 |
RESPONSE TO TOXIC SUBSTANCE |
9 |
241 |
2.86e-06 |
0.0001835 |
73 |
REGULATION OF CELL DEVELOPMENT |
16 |
836 |
2.879e-06 |
0.0001835 |
74 |
POSITIVE REGULATION OF CATALYTIC ACTIVITY |
22 |
1518 |
3.243e-06 |
0.0002039 |
75 |
REGULATION OF ERBB SIGNALING PATHWAY |
6 |
83 |
3.301e-06 |
0.0002048 |
76 |
MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS |
4 |
22 |
3.705e-06 |
0.0002239 |
77 |
NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING |
4 |
22 |
3.705e-06 |
0.0002239 |
78 |
POSITIVE REGULATION OF KINASE ACTIVITY |
12 |
482 |
4.161e-06 |
0.0002451 |
79 |
REGULATION OF NEURON DEATH |
9 |
252 |
4.116e-06 |
0.0002451 |
80 |
NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION |
4 |
23 |
4.468e-06 |
0.0002599 |
81 |
CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS |
5 |
51 |
5.008e-06 |
0.0002877 |
82 |
NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING |
4 |
24 |
5.342e-06 |
0.0003031 |
83 |
NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL |
7 |
139 |
5.498e-06 |
0.0003045 |
84 |
MITOTIC CELL CYCLE CHECKPOINT |
7 |
139 |
5.498e-06 |
0.0003045 |
85 |
INTRACELLULAR SIGNAL TRANSDUCTION |
22 |
1572 |
5.706e-06 |
0.0003124 |
86 |
NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION |
14 |
684 |
6.021e-06 |
0.0003257 |
87 |
REGULATION OF DNA BINDING |
6 |
93 |
6.409e-06 |
0.0003428 |
88 |
CELL DEATH |
17 |
1001 |
6.713e-06 |
0.000349 |
89 |
POSTREPLICATION REPAIR |
5 |
54 |
6.664e-06 |
0.000349 |
90 |
EMBRYO DEVELOPMENT |
16 |
894 |
6.751e-06 |
0.000349 |
91 |
POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
17 |
1004 |
6.983e-06 |
0.0003571 |
92 |
SYNAPTIC SIGNALING |
11 |
424 |
7.314e-06 |
0.0003699 |
93 |
NEGATIVE REGULATION OF RESPONSE TO STIMULUS |
20 |
1360 |
8.01e-06 |
0.0004008 |
94 |
NEGATIVE REGULATION OF CELL DIFFERENTIATION |
13 |
609 |
8.533e-06 |
0.0004224 |
95 |
POSITIVE REGULATION OF TRANSFERASE ACTIVITY |
13 |
616 |
9.64e-06 |
0.0004722 |
96 |
NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY |
4 |
28 |
1.014e-05 |
0.0004864 |
97 |
NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY |
4 |
28 |
1.014e-05 |
0.0004864 |
98 |
ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS |
8 |
217 |
1.15e-05 |
0.0005459 |
99 |
NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY |
4 |
29 |
1.172e-05 |
0.0005507 |
100 |
NEGATIVE REGULATION OF CATALYTIC ACTIVITY |
15 |
829 |
1.191e-05 |
0.000554 |
101 |
SOMITOGENESIS |
5 |
62 |
1.322e-05 |
0.0006085 |
102 |
MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY |
4 |
30 |
1.347e-05 |
0.0006085 |
103 |
GENERATION OF PRECURSOR METABOLITES AND ENERGY |
9 |
292 |
1.347e-05 |
0.0006085 |
104 |
REGULATION OF TRANSFERASE ACTIVITY |
16 |
946 |
1.367e-05 |
0.0006114 |
105 |
NEURON PROJECTION DEVELOPMENT |
12 |
545 |
1.434e-05 |
0.0006354 |
106 |
NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY |
7 |
162 |
1.498e-05 |
0.0006577 |
107 |
REGULATION OF CELL CYCLE ARREST |
6 |
108 |
1.517e-05 |
0.0006595 |
108 |
PROTEIN LOCALIZATION TO MEMBRANE |
10 |
376 |
1.577e-05 |
0.0006796 |
109 |
NEGATIVE REGULATION OF CELL COMMUNICATION |
18 |
1192 |
1.725e-05 |
0.0007366 |
110 |
MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY |
4 |
32 |
1.754e-05 |
0.000742 |
111 |
NEGATIVE REGULATION OF CELL DEVELOPMENT |
9 |
303 |
1.805e-05 |
0.0007434 |
112 |
RESPONSE TO EXTERNAL STIMULUS |
23 |
1821 |
1.798e-05 |
0.0007434 |
113 |
REGULATION OF TYPE I INTERFERON PRODUCTION |
6 |
111 |
1.774e-05 |
0.0007434 |
114 |
REGULATION OF PROTEIN BINDING |
7 |
168 |
1.896e-05 |
0.0007739 |
115 |
CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY |
4 |
33 |
1.989e-05 |
0.0008046 |
116 |
RESPONSE TO ENDOGENOUS STIMULUS |
20 |
1450 |
2.045e-05 |
0.0008203 |
117 |
CARBOHYDRATE METABOLIC PROCESS |
13 |
662 |
2.063e-05 |
0.0008203 |
118 |
NEGATIVE REGULATION OF NEURON DEATH |
7 |
171 |
2.125e-05 |
0.0008381 |
119 |
CELL ACTIVATION |
12 |
568 |
2.157e-05 |
0.0008382 |
120 |
REGULATION OF WNT SIGNALING PATHWAY |
9 |
310 |
2.162e-05 |
0.0008382 |
121 |
NEURON DIFFERENTIATION |
15 |
874 |
2.213e-05 |
0.0008509 |
122 |
REGULATION OF CELLULAR COMPONENT MOVEMENT |
14 |
771 |
2.307e-05 |
0.0008798 |
123 |
AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS |
3 |
12 |
2.431e-05 |
0.0009121 |
124 |
CELL PROLIFERATION |
13 |
672 |
2.412e-05 |
0.0009121 |
125 |
REGULATION OF KINASE ACTIVITY |
14 |
776 |
2.477e-05 |
0.0009181 |
126 |
NEURON APOPTOTIC PROCESS |
4 |
35 |
2.526e-05 |
0.0009181 |
127 |
MEMBRANE PROTEIN PROTEOLYSIS |
4 |
35 |
2.526e-05 |
0.0009181 |
128 |
REGULATION OF ORGAN MORPHOGENESIS |
8 |
242 |
2.523e-05 |
0.0009181 |
129 |
CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING |
5 |
71 |
2.569e-05 |
0.0009266 |
130 |
CELL MATRIX ADHESION |
6 |
119 |
2.634e-05 |
0.0009356 |
131 |
POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY |
6 |
119 |
2.634e-05 |
0.0009356 |
132 |
REGULATION OF MAP KINASE ACTIVITY |
9 |
319 |
2.707e-05 |
0.0009541 |
133 |
REGULATION OF CELL CYCLE PHASE TRANSITION |
9 |
321 |
2.842e-05 |
0.000987 |
134 |
DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE |
4 |
36 |
2.831e-05 |
0.000987 |
135 |
DNA BIOSYNTHETIC PROCESS |
6 |
121 |
2.894e-05 |
0.0009976 |
136 |
POSITIVE REGULATION OF PROTEIN BINDING |
5 |
73 |
2.941e-05 |
0.0009988 |
137 |
G1 DNA DAMAGE CHECKPOINT |
5 |
73 |
2.941e-05 |
0.0009988 |
138 |
OXIDATION REDUCTION PROCESS |
15 |
898 |
3.028e-05 |
0.001021 |
139 |
REGULATION OF CELL DIFFERENTIATION |
20 |
1492 |
3.081e-05 |
0.001031 |
140 |
MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE |
3 |
13 |
3.149e-05 |
0.001046 |
141 |
NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS |
14 |
801 |
3.506e-05 |
0.001157 |
142 |
SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR |
6 |
127 |
3.802e-05 |
0.001237 |
143 |
NEGATIVE REGULATION OF ION TRANSPORT |
6 |
127 |
3.802e-05 |
0.001237 |
144 |
RESPONSE TO ORGANIC CYCLIC COMPOUND |
15 |
917 |
3.851e-05 |
0.001244 |
145 |
NEGATIVE REGULATION OF ENDOCYTOSIS |
4 |
39 |
3.908e-05 |
0.001246 |
146 |
NUCLEOTIDE EXCISION REPAIR DNA INCISION |
4 |
39 |
3.908e-05 |
0.001246 |
147 |
CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE |
3 |
14 |
3.993e-05 |
0.001247 |
148 |
POSITIVE REGULATION OF LIPID METABOLIC PROCESS |
6 |
128 |
3.974e-05 |
0.001247 |
149 |
BIOLOGICAL ADHESION |
16 |
1032 |
3.945e-05 |
0.001247 |
150 |
SOMITE DEVELOPMENT |
5 |
78 |
4.054e-05 |
0.001258 |
151 |
POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS |
16 |
1036 |
4.132e-05 |
0.001264 |
152 |
POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS |
16 |
1036 |
4.132e-05 |
0.001264 |
153 |
MACROMOLECULAR COMPLEX ASSEMBLY |
19 |
1398 |
4.184e-05 |
0.001264 |
154 |
MESENCHYME DEVELOPMENT |
7 |
190 |
4.173e-05 |
0.001264 |
155 |
REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
21 |
1656 |
4.264e-05 |
0.00128 |
156 |
MULTICELLULAR ORGANISMAL MACROMOLECULE METABOLIC PROCESS |
5 |
79 |
4.311e-05 |
0.001282 |
157 |
NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION |
4 |
40 |
4.326e-05 |
0.001282 |
158 |
REGULATION OF NEURON APOPTOTIC PROCESS |
7 |
192 |
4.46e-05 |
0.001313 |
159 |
POSITIVE REGULATION OF BIOSYNTHETIC PROCESS |
22 |
1805 |
4.913e-05 |
0.00142 |
160 |
DNA GEOMETRIC CHANGE |
5 |
81 |
4.864e-05 |
0.00142 |
161 |
PROTEIN LOCALIZATION |
22 |
1805 |
4.913e-05 |
0.00142 |
162 |
JNK CASCADE |
5 |
82 |
5.159e-05 |
0.001482 |
163 |
NEGATIVE REGULATION OF WNT SIGNALING PATHWAY |
7 |
197 |
5.249e-05 |
0.001498 |
164 |
ESTABLISHMENT OF PROTEIN LOCALIZATION |
19 |
1423 |
5.32e-05 |
0.001509 |
165 |
NEGATIVE REGULATION OF MITOTIC CELL CYCLE |
7 |
199 |
5.595e-05 |
0.001578 |
166 |
NEGATIVE REGULATION OF TRANSFERASE ACTIVITY |
9 |
351 |
5.687e-05 |
0.001594 |
167 |
POSITIVE REGULATION OF CELL CYCLE ARREST |
5 |
85 |
6.131e-05 |
0.001708 |
168 |
NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY |
4 |
44 |
6.331e-05 |
0.001743 |
169 |
INTERSTRAND CROSS LINK REPAIR |
4 |
44 |
6.331e-05 |
0.001743 |
170 |
NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
13 |
740 |
6.496e-05 |
0.001778 |
171 |
CELLULAR CATABOLIC PROCESS |
18 |
1322 |
6.728e-05 |
0.001831 |
172 |
REGULATION OF PROTEIN MODIFICATION PROCESS |
21 |
1710 |
6.794e-05 |
0.001838 |
173 |
FC EPSILON RECEPTOR SIGNALING PATHWAY |
6 |
142 |
7.095e-05 |
0.001908 |
174 |
MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS |
3 |
17 |
7.38e-05 |
0.001962 |
175 |
MATURE B CELL DIFFERENTIATION |
3 |
17 |
7.38e-05 |
0.001962 |
176 |
B CELL DIFFERENTIATION |
5 |
89 |
7.639e-05 |
0.001993 |
177 |
SEGMENTATION |
5 |
89 |
7.639e-05 |
0.001993 |
178 |
CELLULAR CARBOHYDRATE METABOLIC PROCESS |
6 |
144 |
7.667e-05 |
0.001993 |
179 |
LYMPHOCYTE DIFFERENTIATION |
7 |
209 |
7.618e-05 |
0.001993 |
180 |
NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION |
6 |
146 |
8.275e-05 |
0.002116 |
181 |
DNA INTEGRITY CHECKPOINT |
6 |
146 |
8.275e-05 |
0.002116 |
182 |
NEURON DEATH |
4 |
47 |
8.225e-05 |
0.002116 |
183 |
IMMUNE RESPONSE |
16 |
1100 |
8.408e-05 |
0.002138 |
184 |
EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING |
11 |
554 |
8.473e-05 |
0.002143 |
185 |
REGULATION OF CELL CYCLE G1 S PHASE TRANSITION |
6 |
147 |
8.593e-05 |
0.002161 |
186 |
REGULATION OF CELL MATURATION |
3 |
18 |
8.825e-05 |
0.002196 |
187 |
LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT |
3 |
18 |
8.825e-05 |
0.002196 |
188 |
POSITIVE REGULATION OF WOUND HEALING |
4 |
48 |
8.939e-05 |
0.002212 |
189 |
LEUKOCYTE DIFFERENTIATION |
8 |
292 |
9.472e-05 |
0.002284 |
190 |
DEFENSE RESPONSE |
17 |
1231 |
9.294e-05 |
0.002284 |
191 |
MULTICELLULAR ORGANISM METABOLIC PROCESS |
5 |
93 |
9.419e-05 |
0.002284 |
192 |
INTERSPECIES INTERACTION BETWEEN ORGANISMS |
12 |
662 |
9.443e-05 |
0.002284 |
193 |
SYMBIOSIS ENCOMPASSING MUTUALISM THROUGH PARASITISM |
12 |
662 |
9.443e-05 |
0.002284 |
194 |
REGULATION OF PHOSPHORUS METABOLIC PROCESS |
20 |
1618 |
9.586e-05 |
0.002299 |
195 |
REGULATION OF CYTOKINE PRODUCTION |
11 |
563 |
9.772e-05 |
0.00232 |
196 |
RESPONSE TO WOUNDING |
11 |
563 |
9.772e-05 |
0.00232 |
197 |
REGULATION OF MITOTIC CELL CYCLE |
10 |
468 |
9.959e-05 |
0.002352 |
198 |
POSITIVE REGULATION OF WNT SIGNALING PATHWAY |
6 |
152 |
0.0001033 |
0.002416 |
199 |
REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
10 |
470 |
0.0001031 |
0.002416 |
200 |
REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY |
4 |
50 |
0.000105 |
0.002443 |
201 |
PEPTIDE METABOLIC PROCESS |
11 |
571 |
0.0001107 |
0.002562 |
202 |
NEGATIVE REGULATION OF CELL ADHESION |
7 |
223 |
0.0001142 |
0.00263 |
203 |
SINGLE ORGANISM CELLULAR LOCALIZATION |
14 |
898 |
0.0001192 |
0.002732 |
204 |
NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION |
5 |
98 |
0.0001207 |
0.00274 |
205 |
MEMBRANE ORGANIZATION |
14 |
899 |
0.0001206 |
0.00274 |
206 |
PROTEIN CATABOLIC PROCESS |
11 |
579 |
0.000125 |
0.002797 |
207 |
CELL PROJECTION ORGANIZATION |
14 |
902 |
0.0001249 |
0.002797 |
208 |
TISSUE DEVELOPMENT |
19 |
1518 |
0.0001256 |
0.002797 |
209 |
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
21 |
1784 |
0.0001243 |
0.002797 |
210 |
MITOTIC DNA INTEGRITY CHECKPOINT |
5 |
100 |
0.0001328 |
0.002943 |
211 |
NEURON DEVELOPMENT |
12 |
687 |
0.0001337 |
0.002949 |
212 |
REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS |
7 |
229 |
0.0001346 |
0.002955 |
213 |
ORGANONITROGEN COMPOUND METABOLIC PROCESS |
21 |
1796 |
0.0001365 |
0.002983 |
214 |
REGULATION OF CELLULAR RESPONSE TO STRESS |
12 |
691 |
0.0001412 |
0.003069 |
215 |
POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION |
16 |
1152 |
0.0001437 |
0.00311 |
216 |
REGULATION OF ION TRANSPORT |
11 |
592 |
0.0001518 |
0.00327 |
217 |
STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE |
5 |
103 |
0.0001526 |
0.003273 |
218 |
CELL SUBSTRATE ADHESION |
6 |
164 |
0.0001567 |
0.003344 |
219 |
ENDOCARDIAL CUSHION MORPHOGENESIS |
3 |
22 |
0.0001642 |
0.003442 |
220 |
REGULATION OF RESPONSE TO EXTERNAL STIMULUS |
14 |
926 |
0.0001642 |
0.003442 |
221 |
NEURON NEURON SYNAPTIC TRANSMISSION |
4 |
56 |
0.0001637 |
0.003442 |
222 |
MACROMOLECULE CATABOLIC PROCESS |
14 |
926 |
0.0001642 |
0.003442 |
223 |
CEREBRAL CORTEX DEVELOPMENT |
5 |
105 |
0.0001671 |
0.003486 |
224 |
INNATE IMMUNE RESPONSE ACTIVATING CELL SURFACE RECEPTOR SIGNALING PATHWAY |
5 |
106 |
0.0001747 |
0.003628 |
225 |
POSITIVE REGULATION OF TRANSPORT |
14 |
936 |
0.0001835 |
0.003795 |
226 |
REGULATION OF NUCLEASE ACTIVITY |
3 |
23 |
0.0001882 |
0.003874 |
227 |
LEUKOCYTE ACTIVATION |
9 |
414 |
0.0001982 |
0.004028 |
228 |
REGULATION OF METAL ION TRANSPORT |
8 |
325 |
0.0001975 |
0.004028 |
229 |
ENDOCYTOSIS |
10 |
509 |
0.0001971 |
0.004028 |
230 |
PROTEIN PHOSPHORYLATION |
14 |
944 |
0.0002004 |
0.004054 |
231 |
REGULATION OF ESTABLISHMENT OF PLANAR POLARITY |
5 |
110 |
0.0002077 |
0.004184 |
232 |
CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
10 |
513 |
0.0002099 |
0.00421 |
233 |
POSITIVE REGULATION OF CELL CYCLE PROCESS |
7 |
247 |
0.0002143 |
0.004226 |
234 |
CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION |
3 |
24 |
0.0002143 |
0.004226 |
235 |
PATTERN SPECIFICATION PROCESS |
9 |
418 |
0.0002129 |
0.004226 |
236 |
REGULATION OF EXECUTION PHASE OF APOPTOSIS |
3 |
24 |
0.0002143 |
0.004226 |
237 |
POSITIVE REGULATION OF LOCOMOTION |
9 |
420 |
0.0002206 |
0.00433 |
238 |
GLIOGENESIS |
6 |
175 |
0.0002229 |
0.004357 |
239 |
REGULATION OF AUTOPHAGY |
7 |
249 |
0.0002251 |
0.004376 |
240 |
CELLULAR AMIDE METABOLIC PROCESS |
12 |
727 |
0.0002257 |
0.004376 |
241 |
POSITIVE REGULATION OF CELL CYCLE |
8 |
332 |
0.0002281 |
0.004405 |
242 |
NUCLEOTIDE EXCISION REPAIR |
5 |
113 |
0.0002355 |
0.004528 |
243 |
REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
8 |
337 |
0.0002523 |
0.004832 |
244 |
REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS |
6 |
181 |
0.0002672 |
0.005087 |
245 |
REGULATION OF DNA METABOLIC PROCESS |
8 |
340 |
0.0002679 |
0.005087 |
246 |
MUSCLE STRUCTURE DEVELOPMENT |
9 |
432 |
0.0002715 |
0.005135 |
247 |
SCHWANN CELL DEVELOPMENT |
3 |
26 |
0.0002733 |
0.005148 |
248 |
LYMPHOCYTE ACTIVATION |
8 |
342 |
0.0002786 |
0.005228 |
249 |
POSITIVE REGULATION OF DNA METABOLIC PROCESS |
6 |
185 |
0.0003005 |
0.005593 |
250 |
REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
12 |
750 |
0.0002998 |
0.005593 |
251 |
NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
7 |
262 |
0.0003066 |
0.005684 |
252 |
NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS |
4 |
66 |
0.0003095 |
0.005685 |
253 |
POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS |
13 |
867 |
0.0003103 |
0.005685 |
254 |
NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY |
4 |
66 |
0.0003095 |
0.005685 |
255 |
CELLULAR MACROMOLECULE LOCALIZATION |
16 |
1234 |
0.0003132 |
0.005714 |
256 |
CELLULAR RESPONSE TO EXTERNAL STIMULUS |
7 |
264 |
0.000321 |
0.005835 |
257 |
POSITIVE REGULATION OF NEURON DEATH |
4 |
67 |
0.0003279 |
0.005937 |
258 |
DNA METABOLIC PROCESS |
12 |
758 |
0.00033 |
0.005952 |
259 |
REGULATION OF DEFENSE RESPONSE |
12 |
759 |
0.000334 |
0.006 |
260 |
PLACENTA BLOOD VESSEL DEVELOPMENT |
3 |
28 |
0.0003419 |
0.006096 |
261 |
AUDITORY RECEPTOR CELL DIFFERENTIATION |
3 |
28 |
0.0003419 |
0.006096 |
262 |
MULTI ORGANISM TRANSPORT |
4 |
68 |
0.0003471 |
0.006142 |
263 |
MULTI ORGANISM LOCALIZATION |
4 |
68 |
0.0003471 |
0.006142 |
264 |
PROTEASOMAL PROTEIN CATABOLIC PROCESS |
7 |
271 |
0.0003758 |
0.006624 |
265 |
RESPONSE TO ARSENIC CONTAINING SUBSTANCE |
3 |
29 |
0.00038 |
0.006673 |
266 |
REGULATION OF MAPK CASCADE |
11 |
660 |
0.0003855 |
0.006744 |
267 |
I KAPPAB KINASE NF KAPPAB SIGNALING |
4 |
70 |
0.0003879 |
0.00676 |
268 |
REGULATION OF WOUND HEALING |
5 |
126 |
0.0003898 |
0.006767 |
269 |
DNA CONFORMATION CHANGE |
7 |
273 |
0.0003928 |
0.006794 |
270 |
ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY |
6 |
195 |
0.000398 |
0.006859 |
271 |
POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS |
15 |
1135 |
0.0004028 |
0.006916 |
272 |
REGULATION OF TRANSPORT |
20 |
1804 |
0.0004095 |
0.006979 |
273 |
REGULATION OF CELL CYCLE PROCESS |
10 |
558 |
0.000409 |
0.006979 |
274 |
REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY |
8 |
365 |
0.0004301 |
0.007304 |
275 |
REGULATION OF IMMUNE SYSTEM PROCESS |
17 |
1403 |
0.0004379 |
0.007408 |
276 |
REGULATION OF ENDOCYTOSIS |
6 |
199 |
0.0004433 |
0.007446 |
277 |
CELLULAR COMPONENT MORPHOGENESIS |
13 |
900 |
0.0004431 |
0.007446 |
278 |
ACTIVATION OF PROTEIN KINASE ACTIVITY |
7 |
279 |
0.0004473 |
0.007487 |
279 |
REGULATION OF LIGASE ACTIVITY |
5 |
130 |
0.0004498 |
0.007502 |
280 |
TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR |
4 |
73 |
0.0004554 |
0.007567 |
281 |
REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL |
7 |
280 |
0.000457 |
0.007567 |
282 |
HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE |
3 |
31 |
0.0004642 |
0.007632 |
283 |
SCHWANN CELL DIFFERENTIATION |
3 |
31 |
0.0004642 |
0.007632 |
284 |
NEGATIVE REGULATION OF BINDING |
5 |
131 |
0.0004659 |
0.007633 |
285 |
REGULATION OF LIPID METABOLIC PROCESS |
7 |
282 |
0.0004768 |
0.007785 |
286 |
B CELL ACTIVATION |
5 |
132 |
0.0004824 |
0.007848 |
287 |
ACTIVATION OF INNATE IMMUNE RESPONSE |
6 |
204 |
0.0005054 |
0.008194 |
288 |
ENDOCARDIAL CUSHION DEVELOPMENT |
3 |
32 |
0.0005104 |
0.008246 |
289 |
MESENCHYMAL CELL DIFFERENTIATION |
5 |
134 |
0.0005167 |
0.008318 |
290 |
NEURON PROJECTION GUIDANCE |
6 |
205 |
0.0005186 |
0.008321 |
291 |
POSITIVE REGULATION OF CELL ADHESION |
8 |
376 |
0.0005232 |
0.008366 |
292 |
FC RECEPTOR SIGNALING PATHWAY |
6 |
206 |
0.0005321 |
0.008449 |
293 |
EXTRACELLULAR MATRIX DISASSEMBLY |
4 |
76 |
0.0005308 |
0.008449 |
294 |
NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS |
5 |
135 |
0.0005345 |
0.008459 |
295 |
REPRODUCTION |
16 |
1297 |
0.0005421 |
0.008551 |
296 |
POSITIVE REGULATION OF MAP KINASE ACTIVITY |
6 |
207 |
0.0005458 |
0.00858 |
297 |
POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
7 |
289 |
0.0005516 |
0.00863 |
298 |
GLIAL CELL DIFFERENTIATION |
5 |
136 |
0.0005527 |
0.00863 |
299 |
ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS |
4 |
77 |
0.0005578 |
0.008651 |
300 |
DETOXIFICATION |
4 |
77 |
0.0005578 |
0.008651 |
301 |
REGULATION OF CELL CELL ADHESION |
8 |
380 |
0.0005608 |
0.00867 |
302 |
VIRAL LIFE CYCLE |
7 |
290 |
0.000563 |
0.008675 |
303 |
ACTIVATION OF MAPK ACTIVITY |
5 |
137 |
0.0005715 |
0.008776 |
304 |
DNA REPAIR |
9 |
480 |
0.000583 |
0.008924 |
305 |
LYMPHOCYTE COSTIMULATION |
4 |
78 |
0.0005857 |
0.008936 |
306 |
CELL CYCLE G2 M PHASE TRANSITION |
5 |
138 |
0.0005907 |
0.008982 |
307 |
REGULATION OF RNA STABILITY |
5 |
139 |
0.0006104 |
0.009251 |
308 |
POSITIVE REGULATION OF CELL PROLIFERATION |
12 |
814 |
0.0006233 |
0.009416 |
309 |
NON CANONICAL WNT SIGNALING PATHWAY |
5 |
140 |
0.0006305 |
0.009495 |
310 |
REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY |
6 |
213 |
0.0006342 |
0.009519 |
311 |
NEGATIVE REGULATION OF CELL CYCLE PROCESS |
6 |
214 |
0.0006499 |
0.009723 |
312 |
REGULATION OF GLYCOGEN METABOLIC PROCESS |
3 |
35 |
0.0006664 |
0.009874 |
313 |
HAIR CELL DIFFERENTIATION |
3 |
35 |
0.0006664 |
0.009874 |
314 |
B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE |
3 |
35 |
0.0006664 |
0.009874 |
315 |
POSITIVE REGULATION OF GENE EXPRESSION |
19 |
1733 |
0.0006712 |
0.009914 |